Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.

Bioorg Med Chem

Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Facultat de Farmàcia i Ciències de l'Alimentació, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Av. Joan XXIII 27-31, Barcelona E-08028, Spain. Electronic address:

Published: October 2019

Soluble epoxide hydrolase (sEH) inhibitors are potential drugs for several diseases. Adamantyl ureas are excellent sEH inhibitors but have limited metabolic stability. Herein, we report the effect of replacing the adamantane group by alternative polycyclic hydrocarbons on sEH inhibition, solubility, permeability and metabolic stability. Compounds bearing smaller or larger polycyclic hydrocarbons than adamantane yielded all good inhibition potency of the human sEH (0.4 ≤ IC ≤ 21.7 nM), indicating that sEH is able to accommodate inhibitors of very different size. Human liver microsomal stability of diamantane containing inhibitors is lower than that of their corresponding adamantane counterparts.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892585PMC
http://dx.doi.org/10.1016/j.bmc.2019.115078DOI Listing

Publication Analysis

Top Keywords

soluble epoxide
8
epoxide hydrolase
8
seh inhibitors
8
metabolic stability
8
polycyclic hydrocarbons
8
inhibitors
5
seh
5
exploring size
4
size lipophilic
4
lipophilic unit
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!